MM Pizzichini, TA Popov, A Efthimiadis, P Hussack, S Evans, E Pizzichini, J Dolovich and FE Hargreave
Asthma Research Group, Department of Medicine, St. Joseph's Hospital, Hamilton, Ontario, Canada.

Inhalation of hypertonic saline to induce sputum may alter cells and fluid-phase markers in sputum. We have compared indices of inflammation in sputum produced spontaneously with sputum induced by an aerosol of hypertonic saline. Twenty-three asthmatics produced spontaneous followed by induced sputum on the same day. The sputum specimen was separated from saliva within 2 h, dispersed with dithiothreitol (DTT) and processed to obtain cytospins and supernatant. The statistical power to detect a 20% difference in sputum parameters was > 90%. Results are expressed as median and interquartile range [IQR]. Induced sputum had a higher proportion of viable cells (77.0 [19.0] versus 47.0 [38.0]%, p < 0.001), less squamous cell contamination (1.0 [1.2] versus 1.8 [34.0]%, p < 0.001) and better quality cytospins (score of 8.0 [4.0] versus 4.0 [2.0], p < 0.001). It also had lower fluid-phase levels of eosinophil cationic protein (ECP) (1,358 [1,102] versus 1,574 [2,479] microg/L) and fibrinogen (1,560.0 [3,130.0] versus 4,350.0 [5,970.0] ng/ml) but only the latter was significantly different (p = 0.02). Induced sputum was similar to spontaneous sputum in weight (200.0 [219.0] versus 270.0 [227.0] mg), total cell count (3.3 [4.1] versus 3.5 [4.5] x 10(6)/ml), proportion of nonsquamous cells, and levels of tryptase. The agreement between induced and spontaneous measurements was good, but fluid-phase levels were affected by the low viability of some spontaneous samples. We conclude that for the indices measured in asthmatic subjects, induced sputum separated from saliva is similar to lower respiratory secretions expectorated spontaneously and has the advantage of better cell viability.

This article has been cited by other articles:

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				E. D. Bateman, S. S. Hurd, P. J. Barnes, J. Bousquet, J. M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S. E. Pedersen, et al. Global strategy for asthma management and prevention: GINA executive summary Eur. Respir. J., January 1, 2008; 31(1): 143 - 178. [Abstract] [Full Text] [PDF]

				A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF]

				M-R. Yacoub, K. Lavoie, G. Lacoste, S. Daigle, J. L'Archeveque, H. Ghezzo, C. Lemiere, and J-L. Malo Assessment of impairment/disability due to occupational asthma through a multidimensional approach Eur. Respir. J., May 1, 2007; 29(5): 889 - 896. [Abstract] [Full Text] [PDF]

				P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]

				E. Bacci, S. Cianchetti, M. Bartoli, F. L. Dente, A. Di Franco, B. Vagaggini, and P. Paggiaro Low Sputum Eosinophils Predict the Lack of Response to Beclomethasone in Symptomatic Asthmatic Patients Chest, March 1, 2006; 129(3): 565 - 572. [Abstract] [Full Text] [PDF]

				W. S. Beckett, D. F. Chalupa, A. Pauly-Brown, D. M. Speers, J. C. Stewart, M. W. Frampton, M. J. Utell, L.-S. Huang, C. Cox, W. Zareba, et al. Comparing Inhaled Ultrafine versus Fine Zinc Oxide Particles in Healthy Adults: A Human Inhalation Study Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1129 - 1135. [Abstract] [Full Text] [PDF]

				L Jayaram, E Pizzichini, C Lemiere, S F P Man, A Cartier, F E Hargreave, and M M M Pizzichini Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast Thorax, February 1, 2005; 60(2): 100 - 105. [Abstract] [Full Text] [PDF]

				K. Maghni, C. Lemiere, H. Ghezzo, W. Yuquan, and J.-L. Malo Airway Inflammation after Cessation of Exposure to Agents Causing Occupational Asthma Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 367 - 372. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				G. Moscato, J-L. Malo, and D. Bernstein Diagnosing occupational asthma: how, how much, how far? Eur. Respir. J., May 1, 2003; 21(5): 879 - 885. [Abstract] [Full Text] [PDF]

				M. L. Aitken, K. E. Greene, M. R. Tonelli, J. L. Burns, J. C. Emerson, C. H. Goss, and R. L. Gibson Analysis of Sequential Aliquots of Hypertonic Saline Solution-Induced Sputum From Clinically Stable Patients With Cystic Fibrosis Chest, March 1, 2003; 123(3): 792 - 799. [Abstract] [Full Text] [PDF]

				A. L. James, P. S. Maxwell, G. Pearce-Pinto, J. G. Elliot, and N. G. Carroll The Relationship of Reticular Basement Membrane Thickness to Airway Wall Remodeling in Asthma Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1590 - 1595. [Abstract] [Full Text] [PDF]

				I S Woolhouse, D L Bayley, and R A Stockley Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis Thorax, August 1, 2002; 57(8): 667 - 671. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: P.L. Paggiaro, Members of the Working Group:, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk Sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 3S - 8s. [Full Text] [PDF]

				S L Traves, S V Culpitt, R E K Russell, P J Barnes, and L E Donnelly Increased levels of the chemokines GRO{alpha} and MCP-1 in sputum samples from patients with COPD Thorax, July 1, 2002; 57(7): 590 - 595. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				D. Cataldo, J.-M. Foidart, L. Lau, P. Bartsch, R. Djukanovic, and R. Louis Induced Sputum : Comparison Between Isotonic and Hypertonic Saline Solution Inhalation in Patients With Asthma Chest, December 1, 2001; 120(6): 1815 - 1821. [Abstract] [Full Text] [PDF]

				R. A. Taha, S. Laberge, Q. Hamid, and R. Olivenstein Increased Expression of the Chemoattractant Cytokines Eotaxin, Monocyte Chemotactic Protein-4, and Interleukin-16 in Induced Sputum in Asthmatic Patients Chest, August 1, 2001; 120(2): 595 - 601. [Abstract] [Full Text] [PDF]

				A. O'BRIEN, P. RUSSO-MAGNO, A. KARKI, S. HIRANNIRAMOL, M. HARDIN, M. KASZUBA, C. SHERMAN, and S. ROUNDS Effects of Withdrawal of Inhaled Steroids in Men with Severe Irreversible Airflow Obstruction Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 365 - 371. [Abstract] [Full Text] [PDF]

				P MAESTRELLI, L RICHELDI, M MORETTI, and L M FABBRI Analysis of sputum in COPD Thorax, June 1, 2001; 56(6): 420 - 422. [Full Text]

				P. E. Silkoff, D. Martin, J. Pak, J. Y. Westcott, and R. J. Martin Exhaled Nitric Oxide Correlated With Induced Sputum Findings in COPD Chest, April 1, 2001; 119(4): 1049 - 1055. [Abstract] [Full Text] [PDF]

				N R Henig, M R Tonelli, M V Pier, J L Burns, and M L Aitken Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis Thorax, April 1, 2001; 56(4): 306 - 311. [Abstract] [Full Text]

				C A Osborne, B J O'Connor, A Lewis, V Kanabar, and W N Gardner Hyperventilation and asymptomatic chronic asthma Thorax, December 1, 2000; 55(12): 1016 - 1022. [Abstract] [Full Text]

				A. Hill, S. Gompertz, and R. Stockley Factors influencing airway inflammation in chronic obstructive pulmonary disease Thorax, November 1, 2000; 55(11): 970 - 977. [Full Text]

				A. Van der Vliet, M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross Myeloperoxidase and protein oxidation in cystic fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L537 - L546. [Abstract] [Full Text] [PDF]

				I. D. PAVORD, R. WARD, G. WOLTMANN, A. J. WARDLAW, J. R. SHELLER, and R. DWORSKI Induced Sputum Eicosanoid Concentrations in Asthma Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1905 - 1909. [Abstract] [Full Text]

				F. E. HARGREAVE and R. LEIGH Induced Sputum, Eosinophilic Bronchitis, and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S53 - 57. [Abstract] [Full Text] [PDF]

				C. E. BRIGHTLING, R. WARD, K. L. GOH, A. J. WARDLAW, and I. D. PAVORD Eosinophilic Bronchitis Is an Important Cause of Chronic Cough Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 406 - 410. [Abstract] [Full Text]

				G. Cox, L. Whitehead, M. Dolovich, M. Jordana, J. Gauldie, and M. T. Newhouse A Randomized Controlled Trial on the Effect of Inhaled Corticosteroids on Airways Inflammation in Adult Cigarette Smokers Chest, May 1, 1999; 115(5): 1271 - 1277. [Abstract] [Full Text] [PDF]

				H. GRASEMANN and F. RATJEN Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 684 - 685. [Full Text] [PDF]

				E. PIZZICHINI, M. M. M. PIZZICHINI, P. GIBSON, K. PARAMESWARAN, G. J. GLEICH, L. BERMAN, J. DOLOVICH, and F. E. HARGREAVE Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1511 - 1517. [Abstract] [Full Text] [PDF]

				A Bhowmik, T A R Seemungal, R J Sapsford, J L Devalia, and J A Wedzicha Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease Thorax, November 1, 1998; 53(11): 953 - 956. [Abstract] [Full Text]